IP Library Granted Patent US 7,811,757
Granted Patent B2
US 7,811,757 · App. 11/517,808 · Granted Oct 12, 2010

Methods for disease detection

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,811,757
App. No.
11/517,808
Granted
Oct 12, 2010
Kind
B2
Abstract

The present invention provides methods for detecting disease by analysis of a patient sample to determine the integrity of nucleic acids in the sample.

Claims (17)

1. A method of detecting fetal abnormality, the method comprising the steps of:

conducting a plurality of amplification reactions on a nucleic acid to produce a plurality of nucleic acid fragments of different lengths, wherein the nucleic acid is obtained from maternal blood comprising fetal cells or fetal cellular debris;

qualitatively determining amplification level in the plurality of amplification reactions; and

identifying fetal abnormality if the qualitative amplification level is greater than a pre-determined threshold level.

2. The method of claim 1 , wherein the fetal abnormality is associated with genomic instability.

3. The method of claim 1 , wherein the step of qualitatively determining comprises:

assigning a binary score to each reaction such that the binary score indicates if a positive amplification takes place; and

determining a total score indicative of the amplification level for the plurality of amplification reactions based on the binary score in each reaction.

4. The method of claim 1 , wherein the plurality of amplification reactions are conducted at a single genomic locus.

5. The method claim 1 , wherein the plurality of amplification reactions are conducted on a plurality of different genomic loci.

6. The method of claim 1 , wherein the pre-determined threshold level is the level of amplification determined in a normal sample.

7. The method of claim 1 , wherein at least one amplified nucleic acid fragment is at least 200 bp in length.

8. The method of claim 1 , wherein at least one amplified nucleic acid fragment is at least 400 bp in length.

9. The method of claim 1 , wherein at least one amplified nucleic acid fragment is at least 800 bp in length.

10. The method of claim 1 , wherein at least one amplified nucleic acid fragment is at least 1.3 Kb in length.

11. The method of claim 1 , wherein at least one amplified nucleic acid fragment is at least 1.8 Kb in length.

12. The method of claim 1 , wherein at least one amplified nucleic acid fragment is at least 2.4 Kb in length.

Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 19, 2011
From: GENZYME CORPORATION
To: ESOTERIX GENETIC LABORATORIES, LLC
Reel/Frame 025656/0581 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 25, 2009
From: EXACT SCIENCES CORPORATION
To: GENZYME CORPORATION
Reel/Frame 022460/0934 →
CHANGE OF NAME Recorded Apr 10, 2008
From: EXACT LABORATORIES, INC.
To: EXACT SCIENCES CORPORATION
Reel/Frame 020783/0304 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 3, 2008
From: SHUBER, ANTHONY P.
To: EXACT LABORATORIES, INC.
Reel/Frame 020751/0068 →